InMed Pharmaceuticals
5 hedge funds and large institutions have $227K invested in InMed Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.
6.15% more ownership
Funds ownership: 0.64% → 6.79% (+6.1%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
15% less capital invested
Capital invested by funds: $266K → $227K (-$39.3K)
62% less funds holding
Funds holding: 13 → 5 (-8)
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$8.67K |
| 2 |
DB
Danske Bank
Copenhagen K,
Denmark
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$13.3K |
| 2 |
Renaissance Technologies
New York
|
-$11.9K |
| 3 |
HF
HRT Financial
New York
|
-$8K |
| 4 |
VF
Virtu Financial
New York
|
-$7K |
| 5 |
BBA
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
|
-$3.84K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AI
1
AdvisorShares Investments
Bethesda,
Maryland
| $177K | +$8.67K | +1,795 | +5% |
|
2
UBS Group
Zurich,
Switzerland
| $49.3K | -$937 | -194 | -2% |
|
|
AWM
3
AllSquare Wealth Management
Albany,
New York
| $5 | – | – | – |
|
|
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $5 | – | – | – |
|
|
DB
5
Danske Bank
Copenhagen K,
Denmark
| $5 | +$5 | +1 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| – | -$13.3K | -2,833 | Closed |
|
|
7
Renaissance Technologies
New York
| – | -$11.9K | -2,515 | Closed |
|
|
HF
8
HRT Financial
New York
| – | -$8K | -1,918 | Closed |
|
|
VF
9
Virtu Financial
New York
| – | -$7K | -1,421 | Closed |
|
|
BBA
10
Baader Bank Aktiengesellschaft
Unterschleissheim,
Germany
| – | -$3.84K | -1,131 | Closed |
|
11
Bank of America
Charlotte,
North Carolina
| – | -$24 | -5 | Closed |
|
12
Osaic Holdings
Scottsdale,
Arizona
| – | -$5 | -1 | Closed |
|
|
GRP
13
Global Retirement Partners
San Rafael,
California
| – | -$1 | – | – |
|
INM Hedge Fund Activity: Q4 2024 in Review
5 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in InMed Pharmaceuticals (INM) for Q4 2024, worth a combined $227K — down 15% from $266K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of INM and 1 opened new positions — a net loss of 7 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was AdvisorShares Investments, adding an estimated $8.67K. The largest seller was Citadel Advisors, exiting entirely with an estimated $13.3K sold.
- 5 institutional investors held InMed Pharmaceuticals (INM) as of Q4 2024, down from 13 in Q3 2024.
- Funds reported $227K of InMed Pharmaceuticals stock for Q4 2024, down 15% quarter-over-quarter.
- 1 fund opened new InMed Pharmaceuticals positions in Q4 2024 and 8 closed out, a net change of -7 holders.
- The largest InMed Pharmaceuticals buyer in Q4 2024 was AdvisorShares Investments, an estimated $8.67K added.
- The largest InMed Pharmaceuticals seller in Q4 2024 was Citadel Advisors, an estimated $13.3K sold.
Based on aggregated 13F filings for Q4 2024.